Northeast Texas Cancer and Research Institute

Tyler, Texas 75702-7522

0 studies enrolling now · 2 studies all time

What they study most

Marginal Zone Lymphoma, Relapsed and/or Refractory Multiple Myeloma (RRMM), Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) — Stopped early